Allergan is buying DERMATOLOGY companies to expand
Post# of 72440
http://www.fiercebiotech.com/biotech/allergan...ajA9In0%3D
Quote:
The deal, worth $21 a share, is a major premium on the $8 a share it was trading on last night before the acquisition was announced, when it had a market cap of $238 million.